Results 151 to 160 of about 78,972 (322)
A case of a gallbladder cancer with marked hypercalcemia and leukocytosis.
Yumiko Watanabe+5 more
openalex +2 more sources
Glucagonoma and Glucagonoma Syndrome: An Updated Review
ABSTRACT Background Glucagonoma is a rare well‐differentiated slowly proliferating pancreatic neuroendocrine tumour, characterized by several manifestations including necrolytic migratory erythema, weight loss, diabetes and anaemia. Aim The purpose of the current review was to acknowledge literature about this rare tumour discerning the clinical ...
Sofia Anelli+8 more
wiley +1 more source
Effects of intraduodenally applied bile salts on pancreatic secretion [PDF]
Lehnert, Peter, Riepl, Rudolf L.
core +1 more source
Estimating the Association and Timing of Occurrence between Obesity and Related Comorbidity Outcomes in a Real‐World Setting: A Cohort Study in the United States. An observational, retrospective cohort study of adults with available body mass index (BMI) data during the period 2010–2019 in a large United States claims‐linked electronic health records ...
Firas Dabbous+9 more
wiley +1 more source
A case of cancer in adenoma of the gallbladder in a patient with gastric cancer.
Yutaka Ozeki+5 more
openalex +2 more sources
This review outlines the potential role of anti‐GPCR autoantibodies in MASLD/MASH, given their involvement in a wide range of diseases and their possible contribution to MASLD/MASH pathophysiology. We also focused on anti‐ApoA1 autoantibodies, sharing functional features with anti‐GPCR autoantibodies and have been shown to promote liver steatosis in ...
Sabrina Pagano+3 more
wiley +1 more source
Dysregulated RNA m6A Methylation Contributes to the Metastasis of Gallbladder Cancer Through miR‐146a‐5p [PDF]
ABSTRACT Gallbladder cancer (GBC) remains a challenging malignancy with a poor prognosis largely due to its highly metastatic nature and lack of effective treatment options. In this study, we investigated the role of N6‐methyladenosine (m6A) modification and its regulatory factors, METTL3 and METTL14, in GBC.
Liu Y+10 more
europepmc +2 more sources
PI5P4K inhibitors: promising opportunities and challenges
Developing inhibitors is like climbing a steep, challenging mountain. PI5P4K inhibitors hold significant promise for the treatment of cancer, immune disorders, and neurological diseases. However, the path to success is fraught with hurdles, and researchers are therefore required to apply their expertise to overcome critical “checkpoints.” While some ...
Koh Takeuchi+16 more
wiley +1 more source